CORDEV

Product description

CORDEV is designed for corneal protection. Indeed, it supports corneal re-epithelization and protect the epithelium. In addition, it shields from UV and blue light. It has a solid scientific background, we have clinical and preclinical data on the product supporting its effectiveness, it is patented, and the brand is registered in the EU. Clinical and preclinical data has generated two published manuscripts on peer review journals. It can be supplied in both standard bottles and in the innovative multidose preservative-free system by SILGAN. It is formulated with two innovative raw materials for ophthalmology and it is registered as Class IIb medical device.

Specifications

Categories	Specialised Finished ProductsPharma and OTC products Dosage FormatsLiquids Eye Health
Supplied from	Italy
Certifications	Health & Safety

More products from D&V farma

DIAX-D

DIAX-D is an innovative, phytocannabinoid-based dietary supplement specifically designed to support retinal health in patients with diabetic retinopathy. Patent pending.
Diabetic retinopathy is a progressive microvascular complication of diabetes, characterized by retinal neur...

More info

DIVICOR

DIVICOR is a product designed to treat corneal alteration in diabetic patients; it has a solid scientific background, we have clinical and preclinical data on the product supporting its effectiveness, it is patented, and the brand is registered in the EU. Clinical and preclinical data have been published i...

More info

NATTOLUX

NATTOLUX is an innovative dietary supplement designed to support vitreous health in patients affected by vitreous degeneration.
Vitreous degeneration is characterized by structural alterations of the collagen network and hyaluronic acid matrix, leading to aggregation phenomena that...

More info

SIALIX

SIALIX is an innovative, phytocannabinoid-based dietary supplement specifically designed to support eye health in patients with glaucoma. Patent pending.
Glaucoma is a neurodegenerative disease characterized by progressive damage to retinal ganglion cells and the optic nerve, poten...

More info